Genetic Study Suggests Link Between Liver Disease and Vascular Dementia

Written By :  Dr Riya Dave
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-03-07 22:00 GMT   |   Update On 2024-03-08 07:10 GMT

Metabolic-dysfunction associated steatotic liver disease (MASLD) has been increasingly recognized as a significant health concern worldwide, with potential implications beyond liver health. Recent studies have explored the relationship between MASLD-related diseases and cognitive function, yet findings have been inconsistent. A recent study aimed to provide clarity on the effects of...

Login or Register to read the full article

Metabolic-dysfunction associated steatotic liver disease (MASLD) has been increasingly recognized as a significant health concern worldwide, with potential implications beyond liver health. Recent studies have explored the relationship between MASLD-related diseases and cognitive function, yet findings have been inconsistent. A recent study aimed to provide clarity on the effects of MASLD-related diseases on cognition and dementia.

This study was published in PloS One journal by Yao-Shuang Li and colleagues. MASLD encompasses a spectrum of liver conditions, including non-alcoholic fatty liver disease (NAFLD), which has been linked to various metabolic disorders.

Researchers utilized mendelian randomization (MR) analysis, a method leveraging genetic variants associated with MASLD-related traits, to investigate causal relationships with cognition and dementia. Three MR methods (inverse-variance weighted, weighted median, and MR-Egger) were employed, along with sensitivity tests to assess the robustness of the results.

Key Findings:

• MR analysis suggested a positive causal association between MASLD confirmed by liver biopsy and liver fibrosis/cirrhosis with vascular dementia (VD).

• However, there was no evidence of a causal link between MASLD-related diseases and cognitive performance or other types of dementia (e.g., Alzheimer's disease, dementia with Lewy bodies).

• Sensitivity tests supported the robustness of the results, indicating the reliability of the findings.

This study highlights a potential link between MASLD-related diseases, particularly liver fibrosis/cirrhosis, and an increased risk of vascular dementia. While further research is needed to confirm these findings and elucidate underlying mechanisms, this study contributes to our understanding of the broader health implications of MASLD.

Healthcare professionals should consider monitoring cognitive function in individuals with MASLD-related liver conditions, particularly those at risk for vascular dementia. Continued investigation into the relationship between liver health and cognitive outcomes is warranted to inform comprehensive patient care strategies.

Reference:

Li Y-S, Xia Y-G, Liu Y-L, Jiang W-R, Qiu H-N, Wu F, et al. (2024) Metabolic-dysfunction associated steatotic liver disease-related diseases, cognition and dementia: A two-sample mendelian randomization study. PLoS ONE 19(2): e0297883. https://doi.org/10.1371/journal.pone.0297883

Tags:    
Article Source : PloS One journal

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News